Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients

Vicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero De Las Heras, Eva Musulén, Luis Palomero, Maria Henar Alonso, Rocio Nieto, Diego Arango, Víctor Moreno, Cristina Queralt, José Luis Manzano, Laura Layos, Cristina Bugés, Eva Martinez-Balibrea

    Research output: Contribution to journalArticleResearch

    8 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients'. Together they form a unique fingerprint.

    Medicine & Life Sciences